Home >> msds >> Bromacil

Bromacil

Print        Favorite
[Fire Fighting]

Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
[Fire Potential]

Active ingredient and dry formulations are non-flammable; the liquid formulation (hyvar-xl) is a combustible mixture which should be kept away from heat and open flame.
[Ingestion]

Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
[Inhalation]

If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
[Skin]

Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists.
[Eyes]

Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.
[Storage]

Store in cool, dry place. Exposure of water-soluble formulations to air can cause some loss of water solubility.
[Handling]

All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
[Ingestion]

Nausea, vomiting, and diarrhea may be noted following ingestion.
[Inhalation]

Symptoms: irritation eyes, skin, upper respiratory system; in animals: thyroid injury Target Organs: Eyes, skin, respiratory system, thyroid.
[Skin]

Cyanosis unresponsive to oxygen therapy may be noted in patients with methemoglobinemia due to absorption of excessive amounts of these agents.
[Eyes]

See inhalation.
[Personal Protection]

Wear appropriate personal protective clothing to prevent skin contact.
[Respirators]

Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
[Exposure limit(s)]

NIOSH REL: TWA 1 ppm (10 mg/m3)
[Poison Class]

4
[Appearance]

Colorless to white odorless crystalline solid. Commercially available as a wettable powder or in liquid formulations.
[Solubility in water]

800 mg/L
[Melting Point]

158 - 159
[Boiling Point]

411
[Vapor Pressure]

.0000003
[Density]

1.55 g/cm3 (20 C)
[pKa/pKb]

9.30 (pKa)
[Partition Coefficient]

2.11
[Usage]

Herbicide.
[Product Name]

5-Bromo-6-methyl-3-(1-methylpropyl)-2,4(1h,3h)-pyrimidinedione
[Synonyms]

5-Bromo-3-sec-butyl-6-methyluracil
5-Bromo-6-methyl-3-(1-methylpropyl)uracil
Herbicide 976
Hyvar X
Hyvarex
[CAS]

"CASEN_314-40-9.htm">314-40-9
[Formula]

C9H13BrN2O2
[Molecular Weight]

261.12
[EINECS]

206-245-1
[RTECS]

YQ9100000
[RTECS Class]

Agricultural Chemical and Pesticide; Mutagen; Reproductive Effector
[Merck]

12,1402
[Beilstein/Gmelin]

647896
[Beilstein Reference]

5-24-07-00040
[Small spills/leaks]

Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
[Stability]

Stable up to MP and slowly sublimes @ temperature just below its MP active ingredient is chemically stable under normal storage conditions stable in aqueous bases. Slowly decomposed by concentrated acids.
[Incompatibilities]

Strong oxidizing agents.
[Decomposition]

When heated to decomposition it emits very toxic fumes of hydrogen bromide and nitrogen oxides.